Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the U.S. Securities and Exchange Commission ("Commission") on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Amendment No. 4 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 73,038,253 shares of Common Stock of the Issuer (approximately 25.7% of the outstanding shares of Common Stock of the Issuer), of which 29,215,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on November 12, 2025. Although the WP Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each WP Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such WP Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,093,929 shares of Common Stock outstanding as of October 28, 2025 as reported on the Issuer's final prospectus reported on Form 424B7, filed on November 7, 2025.


SCHEDULE 13G



 
WP XI Partners, L.P.
 
Signature:/s/ Warburg Pincus XI, L.P.
Name/Title:Warburg Pincus XI, L.P / General Partner
Date:11/12/2025
 
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WARBURG PINCUS PRIVATE EQUITY XI, L.P.
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti, Partner
Date:11/12/2025
 
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Partner
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WARBURG PINCUS XI PARTNERS, L.P.
 
Signature:/s/ Warburg Pincus XI, L.P.
Name/Title:Warburg Pincus XI, L.P. / General Partner
Date:11/12/2025
 
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WARBURG PINCUS PRIVATE EQUITY XI-B, L.P.
 
Signature:/s/ Warburg Pincus XI, L.P.
Name/Title:Warburg Pincus XI, L.P. / General Partner
Date:11/12/2025
 
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WARBURG PINCUS PRIVATE EQUITY XI-C, L.P.
 
Signature:/s/ Warburg Pincus (Cayman) XI, L.P.
Name/Title:Warburg Pincus (Cayman) XI, L.P. / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus XI-C, LLC
Name/Title:Warburg Pincus XI-C, LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners II (Cayman), L.P.
Name/Title:Warburg Pincus Partners II (Cayman), L.P. / Managing Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:11/12/2025
 
BULL CO-INVEST L.P.
 
Signature:/s/ WP Bull Manager LLC
Name/Title:WP Bull Manager LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Memeber
Date:11/12/2025
 
WARBURG PINCUS XI, L.P.
 
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Manging Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners GP LLC.
Name/Title:Warburg Pincus Partners GP LLC. / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Manging Member
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WP GLOBAL LLC
 
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partners
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co / Managing Member
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WARBURG PINCUS PARTNERS II, L.P.
 
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WARBURG PINCUS PARTNERS GP LLC.
 
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti
Date:11/12/2025
 
WARBURG PINCUS & CO.
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:11/12/2025
 
WARBURG PINCUS (CAYMAN) XI, L.P.
 
Signature:/s/ Warburg Pincus XI-C, LLC
Name/Title:Warburg Pincus XI-C, LLC / General Partner
Date:11/12/2025
 
Signature:/s/ Warburg Pincus Partners II (Cayman), L.P.
Name/Title:Warburg Pincus Partners II (Cayman), L.P. / Managing Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:11/12/2025
 
WARBURG PINCUS XI-C, LLC.
 
Signature:/s/ Warburg Pincus Partners II (Cayman), L.P.
Name/Title:Warburg Pincus Partners II (Cayman), L.P. / Managing Member
Date:11/12/2025
 
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:11/12/2025
 
Signature:/s/ / Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:11/12/2025
 
WARBURG PINCUS PARTNERS II (CAYMAN), L.P.
 
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:11/12/2025
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:11/12/2025
 
WARBURG PINCUS (BERMUDA) PRIVATE EQUITY GP LTD.
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:11/12/2025
 
WARBURG PINCUS LLC
 
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Managing Director
Date:11/12/2025
Exhibit Information

Exhibit 99.1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* * Incorporated herein by reference to the Agreement of Joint Filing by Warburg Pincus Private Equity XI, L.P., Warburg Pincus XI Partners, L.P., Warburg Pincus Private Equity XI-B, L.P., WP XI Partners, L.P., Warburg Pincus Private Equity XI-C, L.P., Bull Co-Invest L.P., Warburg Pincus XI, L.P., WP Global LLC, Warburg Pincus Partners II, L.P., Warburg Pincus Partners GP LLC, Warburg Pincus & Co., Warburg Pincus (Cayman) XI, L.P., Warburg Pincus XI-C, LLC, Warburg Pincus Partners II (Cayman), L.P., Warburg Pincus (Bermuda) Private Equity GP LTD., and Warburg Pincus LLC ("Warburg Pincus Funds") dated as of February 14, 2022, which was previously filed with the Commission as Exhibit 99.1 to Amendment No. 1 to Schedule 13G filed by the Warburg Pincus Funds on February 14, 2022 with respect to the shares of common stock of Sotera Health Co.